XML 36 R21.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Income Taxes | 12 Months Ended
--- | ---
Dec. 31, 2023
Income Tax Disclosure [Abstract] |
Income Taxes | Note 13. Income Taxes Net loss before provision for income taxes consisted of the following (in thousands):
| Year ended December 31,
| 2023 |  | 2022 |  | 2021
United States | $ | (190,912) |  |  | $ | (898,036) |  |  | $ | (394,392) |
International | 34,067 |  |  | 23,983 |  |  | 20,670 |
Total net loss before provision for income taxes | $ | (156,845) |  |  | $ | (874,053) |  |  | $ | (373,722) |
The provision for income taxes consisted of the following (in thousands):
| Year ended December 31,
| 2023 |  | 2022 |  | 2021
Current |  |  |  |  |
Federal | $ | — |  |  | $ | — |  |  | $ | — |
State | 1,792 |  |  | 1,104 |  |  | 746 |
Foreign | 5,972 |  |  | 4,710 |  |  | 3,580 |
Total current | $ | 7,764 |  |  | $ | 5,814 |  |  | $ | 4,326 |
Deferred |  |  |  |  |
Federal | $ | — |  |  | $ | — |  |  | $ | — |
State | — |  |  | — |  |  | — |
Foreign | 631 |  |  | (701) |  |  | (1,798) |
Total deferred | 631 |  |  | (701) |  |  | (1,798) |
Total income tax provision | $ | 8,395 |  |  | $ | 5,113 |  |  | $ | 2,528 |
Beginning in 2022, the Tax Cuts and Jobs Act of 2017 eliminated the right to deduct research and development expenditures for tax purposes in the period the expenses were incurred and instead requires all U.S. and foreign research and development expenditures to be amortized over five and fifteen tax years, respectively. Due to this required capitalization of research and development expenditures, the Company has recorded current income tax expense of $1.8 million for the year ended December 31, 2023. The current income tax provision is primarily for foreign and state taxes currently payable that we anticipate paying as a result of statutory limitations on our ability to offset expected taxable income with net operating loss carry forwards in certain states. The provision for income taxes differed from the amounts computed by applying the U.S. federal income tax rate to pretax loss as a result of the following (in thousands):
| Year ended December 31,
| 2023 |  | 2022 |  | 2021
Federal tax benefit at statutory rate | $ | (32,937) |  |  | $ | (183,551) |  |  | $ | (78,482) |
State tax, net of federal tax benefit | 1,415 |  |  | 848 |  |  | 314 |
Research and development credits | (11,574) |  |  | (12,830) |  |  | (10,135) |
Share-based compensation | 10,956 |  |  | 5,828 |  |  | (45,501) |
Loss on debt extinguishment | — |  |  | 19 |  |  | 365 |
Other permanent differences | 1,674 |  |  | 3,143 |  |  | 835 |
Global intangible low-taxed income | 3,035 |  |  | — |  |  | — |
Foreign tax rate differential | 548 |  |  | (2,497) |  |  | (4,104) |
Net operating losses not recognized | 35,278 |  |  | 194,153 |  |  | 139,236 |
Release of valuation allowance associated with acquisitions | — |  |  | — |  |  | — |
Total income tax provision | $ | 8,395 |  |  | $ | 5,113 |  |  | $ | 2,528 |
In general, it is the Company’s practice and intention to reinvest the earnings of its non-U.S. subsidiaries in those operations. Because the Company’s non-U.S. subsidiary earnings have previously been subject to the one-time transition tax on foreign earnings required by the 2017 Tax Act, any additional taxes due with respect to such earnings or the excess of the amount for financial reporting over the tax basis of its foreign investments would generally be limited to foreign withholding taxes and/or U.S. state income taxes. The types of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities are as follows (in thousands):
| Year ended December 31,
| 2023 |  | 2022
Deferred tax assets |  |  |
Net operating loss and credit carry-forwards | $ | 463,400 |  |  | $ | 491,323 |
Research and development credits | 87,111 |  |  | 71,756 |
Research and development expenditure capitalization | 130,792 |  |  | 75,821 |
Basis difference in investments | 40,655 |  |  | 107,756 |
Sales tax accrual | 67 |  |  | 90 |
Share-based compensation | 21,014 |  |  | 14,986 |
Acquired intangibles | 76,171 |  |  | 50,156 |
Accrued liabilities | 17,994 |  |  | 16,550 |
Gross deferred tax assets | 837,204 |  |  | 828,438 |
Valuation allowance | (674,720) |  |  | (669,690) |
Total deferred tax assets | 162,484 |  |  | 158,748 |
Deferred tax liabilities |  |  |
Deferred sales commissions | (117,875) |  |  | (117,724) |
Lease right of use assets | (8,255) |  |  | (7,045) |
Property and equipment | (35,753) |  |  | (32,746) |
Net deferred tax assets | $ | 601 |  |  | $ | 1,233 |
As of December 31, 2023, the Company has federal net operating loss carryforwards of approximately $1.8 billion, of which $66.1 million will expire in 2037, while the remaining portion does not expire. As of December 31, 2023, the Company had foreign net operating loss carryforwards of approximately $27.1 million that will carryforward indefinitely. As of December 31, 2023, the Company had state net operating loss carryforwards of approximately $1.3 billion that will begin to expire in 2024. The Company also has research credit carryforwards for federal and California tax purposes of approximately $77.0 million and $49.5 million, respectively, available to reduce future income subject to income taxes. The federal research credit carry-forwards will begin to expire in 2028 and the California research credits carry forward indefinitely. The Internal Revenue Code of 1986, as amended, imposes restrictions on the utilization of net operating losses in the event of an “ownership change” of a corporation. Accordingly, a company’s ability to use net operating losses may be limited as prescribed under Internal Revenue Code Section 382 (“IRC Section 382”). Events which may cause limitations in the amount of the net operating losses that the Company may use in any one year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. Utilization of the federal and state net operating losses may be subject to substantial annual limitation due to the ownership change limitations provided by the IRC Section 382 and similar state provisions. The Company’s management believes that, based on a number of factors, it is more likely than not, that all or some portion of the deferred tax assets will not be realized; and accordingly, for the year ended December 31, 2023, the Company has provided a valuation allowance against the Company’s U.S. net deferred tax assets. The net change in the valuation allowance for the years ended December 31, 2023 and 2022 was an increase of $5.0 million and $244.1 million, respectively. The following shows the changes in the gross amount of unrecognized tax benefits as of December 31, 2023 (in thousands):
| 2023 |  | 2022 |  | 2021
Unrecognized tax benefits, beginning of the year | $ | 26,412 |  |  | $ | 20,010 |  |  | $ | 14,158 |
Increases related to prior year tax positions | — |  |  | — |  |  | — |
Decreases related to prior year tax positions | (418) |  |  | — |  |  | — |
Increases related to current year tax positions | 5,982 |  |  | 6,402 |  |  | 5,852 |
Unrecognized tax benefits, end of year | $ | 31,976 |  |  | $ | 26,412 |  |  | $ | 20,010 |
In accordance with ASC 740-10, Income Taxes, the Company has adopted the accounting policy that interest and penalties recognized are classified as part of its income taxes. The Company does not anticipate that its total unrecognized tax benefits will significantly change due to settlement of examination or the expiration of statute of limitations during the next 12 months. Included in the balance of unrecognized tax benefits as of December 31, 2023 are $0.3 million of tax benefit that, if recognized, would affect the effective tax rate. Otherwise, as a result of the full valuation allowance as of December 31, 2023, current adjustments to the unrecognized tax benefit will not have an impact on our effective income tax rate. Any adjustments made after the valuation allowance is released will have an impact on the tax rate. The Company files U.S. and foreign income tax returns with varying statutes of limitations. Due to the Company’s net carry-over of unused operating losses and tax credits, all years from 2003 forward remain subject to future examination by tax authorities.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//740/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration